References
- Ball AL, Rana S, Dehne KL. HIV prevention among injecting drug users: Responses in developing and transitional countries. Public Health Report 1998; 113: 170–181
- Bogart LM, Kral A, Scott A, Anderson R, Flynn N, Gilbert ML, Bluthenthal RN. Sexual risk among injection drug users recruited from syringe exchange programs in California. Sexually Transmitted Diseases 2005; 32: 27–34
- Crofts N, Aitken CK, Kaldor JM. The force of numbers: Why hepatitis C is spreading among Australian injecting drug users while HIV is not. Medical Journal Of Australia 1999; 170: 220–221
- Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS 2000; 14: 717–726
- Epele ME. Changing Cocaine Use Practices: Neo-liberalism, HIV-AIDS, and Death in an Argentine Shantytown. Subst Use and Misuse 2003; 38: 1189–1216
- Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 1997; 349: 1797–1800
- Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005; 366: 316–318
- Miller CL, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, Schechter MT. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002; 36: 737–742
- Miller CL, Kerr T, Frankish JC, Spittal PM, Li K, Schechter MT, Wood E. Binge drug use independently predicts HIV seroconversion among injection drug users: Implications for public health strategies. Subst Use and Misuse 2006; 41: 199–210
- Neaigus A, Friedman SR, Jose B, Goldstein MF, Curtis R, Ildefonso G, Des Jarlais DC. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. Journal of Acquired Immune Deficiency Syndromes 1996; 11: 499–509
- Rhodes T, Mikhailova L, Sarang A, Lowndes CM, Rylkov A, Khutorskoy M, Renton A. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment. Social Science and Medicine 2003; 57: 39–54
- Sherman S, Latkin C, Gielen AC. Social factors related to syringe sharing among injecting partners: A focus on gender. Subst Use and Misuse 2001; 36: 2113–2136
- Strathdee S, Vlahov D. The effectiveness of needle exchange programs: A review of the science and policy. AIDScience 2001; 1
- Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, Schechter MT. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003; 17: 887–893
- Wood E, Stoltz JA, Montaner JS, Kerr T. Evaluating methamphetamine use and risks of injection initiation among street youth: The ARYS study. Harm Reduction Journal 2006; 3: 1–33
- Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?. Canadian Medical Association Journal 2001; 165: 405–410
- Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 2002; 16: 941–943